# Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome

> **NCT03173937** · PHASE1,PHASE2 · RECRUITING · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 37 (estimated)

## Conditions studied

- Severe Aplastic Anemia
- Hypo-Plastic MDS
- Myelodysplastic Syndrome (MDS)

## Interventions

- **BIOLOGICAL:** Omidubicel (former CordIn)
- **DEVICE:** Miltenyi CliniMACS(R) CD34 Reagent System

## Key facts

- **NCT ID:** NCT03173937
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2017-06-13
- **Primary completion:** 2027-04-28
- **Final completion:** 2032-03-01
- **Target enrollment:** 37 (ESTIMATED)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03173937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03173937, "Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03173937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*